ALEXANDRIA, Va., April 9 -- United States Patent no. 12,269,855, issued on April 8, was assigned to INNOVENT BIOLOGICS (SUZHOU) Co. LTD. (Jiangsu, China).
"Interleukin-2 and use thereof" was invented by Lishan Kang (Jiangsu, China), Chunyin Gu (Jiangsu, China), Fenggen Fu (Jiangsu, China), Shuaixiang Zhou (Jiangsu, China), Xinzhen Shi (Jiangsu, China) and Junjian Liu (Jiangsu, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel interleukin-2 (IL-2) mutant protein and use thereof. In particular, the present invention relates to an IL-2 mutant protein with reduced IL-2RAlpha receptor binding ability and/or increased IL-2RBeta receptor binding ability compared with the ...